Frazier Life Sciences IX L.P. 13D/13G Filings for Krystal Biotech, Inc. (KRYS)

Frazier Life Sciences IX L.P. 13D and 13G filings for Krystal Biotech, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-04
4:35 pm
Unchanged
2020-12-3113GKrystal Biotech, Inc.
KRYS
Frazier Life Sciences IX L.P.895,000
4.500%
0
(Unchanged)
Filing